Outcome of tocilizumab treatment in refractory ocular inflammatory diseases

Tocilizumab and steroid boli for treatment-resistant anterior necrotizing scleritis

(2015) Jan Tode et al.   ACTA OPHTHALMOLOGICA

Longterm Safety and Effectiveness of the Anti-interleukin 6 Receptor Monoclonal Antibody Tocilizumab in Patients with Systemic Juvenile Idiopathic Arthritis in Japan

(2014) S. Yokota et al.   JOURNAL OF RHEUMATOLOGY

Long-Term Effects of Tocilizumab Therapy for Refractory Uveitis-Related Macular Edema

(2014) Marina Mesquida et al.   OPHTHALMOLOGY

Tocilizumab treatment for refractory uveitis-related cystoid macular edema

(2013) Alfredo Adán et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Effectiveness and Safety of Tocilizumab: Postmarketing Surveillance of 7901 Patients with Rheumatoid Arthritis in Japan

(2013) T. Koike et al.   JOURNAL OF RHEUMATOLOGY

Analysis of a Novel Protocol of Pulsed Intravenous Cyclophosphamide for Recalcitrant or Severe Ocular Inflammatory Disease

(2013) Ana M. Suelves et al.   OPHTHALMOLOGY

Is Tocilizumab an Effective Option for Treatment of Refractory Uveitis Associated with Juvenile Idiopathic Arthritis?

(2012) C. TAPPEINER et al.   JOURNAL OF RHEUMATOLOGY

Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis

(2012) Fabrizio De Benedetti et al.   NEW ENGLAND JOURNAL OF MEDICINE

Understanding uveitis: The impact of research on visual outcomes

(2011) Marc D. de Smet et al.   PROGRESS IN RETINAL AND EYE RESEARCH

Systemic Therapy With Conventional and Novel Immunomodulatory Agents for Ocular Inflammatory Disease

(2011) Khayyam Durrani et al.   SURVEY OF OPHTHALMOLOGY

Tocilizumab

(2010) Adith Venkiteshwaran   mAbs

Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial

(2008) Josef S Smolen et al.   LANCET